BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poor SR, Ettcheto M, Cano A, Sanchez-Lopez E, Manzine PR, Olloquequi J, Camins A, Javan M. Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment. Pharmaceuticals (Basel) 2021;14:890. [PMID: 34577590 DOI: 10.3390/ph14090890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-kuraishy HM, Al-gareeb AI, Alsayegh AA, Hakami ZH, Khamjan NA, Saad HM, Batiha GE, De Waard M. A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease. Neurochem Res 2022. [DOI: 10.1007/s11064-022-03817-4] [Reference Citation Analysis]
2 Triggle CR, Mohammed I, Bshesh K, Marei I, Ye K, Ding H, Macdonald R, Hollenberg MD, Hill MA. Metformin: Is it a drug for all reasons and diseases? Metabolism 2022. [DOI: 10.1016/j.metabol.2022.155223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kim S. 4-Hexylresorcinol: pharmacologic chaperone and its application for wound healing. Maxillofac Plast Reconstr Surg 2022;44. [DOI: 10.1186/s40902-022-00334-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]